Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 391-400 of 682 for cancer

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. PRGN-3006 Adoptive Cellular Therapy For CD33-Positive Relapsed Or Refractory AML, MRD Positive AML Or Higher Risk MDS

    Rochester, MN

  2. Individualizing Approaches To Surveillance Mammography In Older Breast Cancer Survivors - The I-MAMMO Study

    Rochester, MN

  3. Hyperthermic Intraperitoneal Chemotherapy With Cisplatin And Paclitaxel For Gastric Cancer At High Risk Of Peritoneal Recurrence

    Rochester, MN

  4. Global Trial In APG2575 For Patients With CLL/​SLL

    Jacksonville, FL

  5. A Study To Evaluate Bleomycin, Carboplatin, Etoposide, Or Cisplatin In Treating Pediatric And Adult Patients With Germ Cell Tumors

    Rochester, MN

  6. Acceptance And Commitment Therapy Compassion-Based Virtual Group Intervention For Diverse Cancer Patients

    Scottsdale/Phoenix, AZ

  7. Trial Of Neoadjuvant Enoblituzumab Vs SOC In Men With High-Risk Localized Prostate Cancer

    Rochester, MN

  8. The LYMPH Trial - Microsurgical Versus Conservative Treatment Of Chronic Breast Cancer Associated Lymphedema

    Rochester, MN

  9. Focal US-guided Cryo-ablation Using DynaCAD / UroNAV Preplanning / Guidance Of Intermediate Risk Prostate Cancer

    Rochester, MN

  10. Schedule De-Escalation Of 177Lu-PSMA-617 For The Treatment Of Metastatic Castrate Resistant Prostate Cancer

    Rochester, MN

.

Mayo Clinic Footer